Thermo Fisher Scientific INC THER.../ US8835561023 /
| 24.05.2024 16:56:07 | Diff. - | Volumen | Geld06:00:05 | Brief06:00:05 | Marktkapitalisierung | Dividendenr. | KGV |
|---|---|---|---|---|---|---|---|
| 583,64USD | - | 225 Umsatz: 74.962,56 |
-Geld Vol: - | -Brief Vol: - | 212,63 Mrd.USD | 0,25% | 35,82 |
Aktiva
|
2010 US GAAP in Mio. USD |
2011 US GAAP in Mio. USD |
2012 US GAAP in Mio. USD |
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sachanlagen | 1.408,6000 | 1.656,2000 | 1.726,4000 | 1.767,4000 | 2.426,5000 | ||||||
| Immaterielle Vermögensgegenstände | 6.041,1000 | 7.815,9000 | 7.804,5000 | 7.071,3000 | 14.110,1000 | ||||||
| Finanzanlagen | - | - | - | - | - | ||||||
| Anlagevermögen | - | - | - | - | 36.312,3000 | ||||||
| Vorräte | 1.175,1000 | 1.355,4000 | 1.443,3000 | 1.494,5000 | 1.859,5000 | ||||||
| Forderungen | 1.516,8000 | 1.814,1000 | 1.804,9000 | 1.942,3000 | 2.473,6000 | ||||||
| Liquide Mitteln | 917,1000 | 1.016,3000 | 851 | 5.826 | 1.343,5000 | ||||||
| Umlaufvermögen | 4.135 | 4.821,9000 | 4.834,8000 | 9.880,7000 | 6.539,8000 | ||||||
| Aktiva, gesamt | 21.349,4000 | 26.833,7000 | 27.444,6000 | 31.863,4000 | 42.852,1000 | ||||||
Passiva
|
2010 US GAAP in Mio. USD |
2011 US GAAP in Mio. USD |
2012 US GAAP in Mio. USD |
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Verbindlichkeiten aus Lieferungen und Leistungen | 551 | 628,7000 | 641,4000 | 691,5000 | 820,7000 | ||||||
| Langfristige Schulden | - | - | - | - | 12.351,6000 | ||||||
| Verbindlichkeiten gegenüber Kreditinstituten | 105,8000 | 1.272,8000 | 93,1000 | 987,7000 | 2.212,4000 | ||||||
| Rückstellungen | 1.684,4000 | 2.230,9000 | 2.047,2000 | 1.609,9000 | 3.430,7000 | ||||||
| Verbindlichkeiten | 5.988,4000 | 11.795,6000 | 11.979,9000 | 15.007,3000 | 22.304 | ||||||
| Gezeichnetes Kapital | 401,8000 | 406,4000 | 413,5000 | 369,6000 | 408,5000 | ||||||
| Eigenkapital | 15.361 | 15.038,1000 | 15.464,7000 | 16.856,1000 | 20.548,1000 | ||||||
| Minderheitenanteile | - | - | - | - | - | ||||||
| Passiva, gesamt | 21.349,4000 | 26.833,7000 | 27.444,6000 | 31.863,4000 | 42.852,1000 | ||||||
Gewinn- und Verlustrechnung
|
2010 US GAAP in Mio. USD |
2011 US GAAP in Mio. USD |
2012 US GAAP in Mio. USD |
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 10.788,7000 | 11.725,9000 | 12.509,9000 | 13.090,3000 | 16.889,6000 | ||||||
| Abschreibungen (Gesamt) | - | - | - | - | - | ||||||
| Betriebsergebnis | 1.264,9000 | 1.245,2000 | 1.482,1000 | 1.609,6000 | 2.503 | ||||||
| Zinsergebnis | - | - | - | - | - | ||||||
| Ergebnis vor Steuern | 1.164,6000 | 1.126,6000 | 1.269,4000 | 1.319,5000 | 2.087,2000 | ||||||
| Ertragsteuern | 131,5000 | 107 | 11 | 40,4000 | -191,7000 | ||||||
| Gewinnanteil Minderheitsgesellschafter | 0.0000 | 0.0000 | 0.0000 | 0.0000 | - | ||||||
| Konzernjahresüberschuss | 1.035,6000 | 1.329,9000 | 1.177,9000 | 1.273,3000 | 1.894,4000 | ||||||
Pro Aktie
Cash Flow
|
2010 US GAAP in Mio. USD |
2011 US GAAP in Mio. USD |
2012 US GAAP in Mio. USD |
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow aus laufender Geschäftstätigkeit | 1.497,8000 | 1.691 | 2.039,5000 | 2.010,7000 | 2.619,6000 | ||||||
| Cash Flow aus Investitionstätigkeit | -858,9000 | -5.142,2000 | -1.325,8000 | -263,3000 | -11.782,7000 | ||||||
| Cash Flow aus Finanzierungstätigkeit | -1.295,1000 | 3.550,6000 | -917,7000 | 3.310 | 4.796,1000 | ||||||
| Veränderung der liquiden Mittel | -647 | 99,2000 | -165,3000 | 5.020,4000 | -4.482,5000 | ||||||
| Anzahl der Mitarbeiter | 37.200 | 39.300 | 38.900 | 50.000 | 51.000 | ||||||
